Thus, in thyroid carcinoma cells, which harbor activated RET/PTC, RAS, or BRAF, CD44-ICD accumulated, a blockade of γ-secretase blunting CD44 processing (De Falco et al., 2012). Here, CD44 is linked to thyroid gland carcinoma.